MDxHealth SA (MDXH) Misses Q2 EPS by 15c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St futures muted as investors monitor US-Iran negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
BTIG Reiterates Buy Rating on MDxHealth SA (MDXH)
August 23, 2024 5:05 AM EDTBTIG analyst Mark Massaro reiterated a Buy rating and $8.00 price target on MDxHealth SA (NASDAQ: MDXH)
The analyst comments "As pre-announced, MDXH reported a Q2 revenue beat and raised its 2024 revenue guide slightly in excess of the beat, marking another solid quarter of... More
